ArticleIncreased level of salivary prostaglandins in patients with major depression
References (46)
- et al.
Identification of prostaglandin D2 as a major prostaglandin in homogenates of rat brain
Prostaglandins
(1977) - et al.
Depression, immunocompetence, and prostaglandins of the E series
Psychiatry Res
(1986) - et al.
Prostaglandin E2 regulation of human specific B-cell response: Interaction with a monocyte product
Clin Immunol Immunopathol
(1983) - et al.
Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain
Brain Res
(1982) - et al.
Regulation of the immune response by prostaglandins
Clin Immunol Immunopathol
(1980) - et al.
Alterations in nociception after intracisternal administration of prostaglandin D2, E2 or F2α to conscious mice
Eur J Pharmacol
(1986) - et al.
Impaired lymphocyte function in depressive illness
Life Sci
(1983) - et al.
Elevated levels of prostaglandin E2 and thromboxane B2 in depression
Prostagland Leukotriens Med
(1983) False normal Dexamethasone Suppression Test and indomethacin
Lancet
(1982)- et al.
Plasma prostaglandin ez metabolite—measured as 11-deoxy-15-keto-13,14-dihydro-11β,16C-cyclo-PGE2—in twins with schizophrenic disorder
Biol Psychiatry
(1986)
Prostaglandin D2 in rat brain, spinal cord and pituitary: Basal level and regional distribution
Life Sci
Effect of prostaglandin D2 on pain and inflammation
Jpn J Pharmacol
Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica
Prostaglandins
Human salivary eicosanoids: Circadian variation
Biochem Biophys Res Commun
Prostaglandin D2 induced sleep when microinjected into the preoptic area of conscious rats
Biochem Biophys Res Commun
Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet-rich plasma
J Biol Chem
NADP-linked 15-hydroxyprostaglandin dehydrogenase for prostaglandin D2 in human blood platelets
Arch Biochem Biophys
Prostaglandins and the central nervous system
Arch Intern Med
Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandin E2 and F2α
Psychopharmacology
Salivation in depressed patients
Arch Gen Psychiatry
The effects of prostaglandins on ACTH secretion
Endocrinology
Use of saliva in therapeutic drug monitoring
Clin Chem
Differential sleeppromoting effects of five sleep substances nocturnally infused in unrestrained rats
Cited by (123)
Modulation of the inflammatory response exerts beneficial effects on anger in treatment-resistant bipolar depression
2023, Journal of Affective Disorders ReportsIdentification of adolescent patients with depression via assessment of the niacin skin flushing response
2023, Journal of Affective DisordersUnraveling the complex interplay of immunometabolic systems that contribute to the neuroprogression of psychiatric disorders
2019, Neurology Psychiatry and Brain ResearchKynurenine pathway in depression: A systematic review and meta-analysis
2018, Neuroscience and Biobehavioral ReviewsPlasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment
2018, Journal of Psychiatric ResearchMetabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target
2018, Neuroscience and Biobehavioral ReviewsCitation Excerpt :The extensive variability in the measurement of cytokine levels within and between laboratories (Noble et al., 2008), and substantial heterogeneity between studies comparing cytokines between patients to controls (Kohler et al., 2017), or comparing patients to themselves pre- vs. post-treatment (Hannestad et al., 2011), suggests suboptimal utility as diagnostic or prognostic biomarkers. Considerably less work has examined the possibility of lipid metabolic biomarkers, although prostaglandins measured quantitatively have shown promise (Calabrese et al., 1986; Nishino et al., 1989; Ohishi et al., 1988). There exists a clear need to identify specific markers of inflammation in depressive disorders, the sources of heterogeneity in related inflammatory pathways, and the underlying causes.